Together to
build trust

What makes APCER Life Sciences different is the way we work together with our clients. We understand that trust is earned one project at a time, and we’ll start with a project as small as a single aggregate safety report to demonstrate the quality of our work. On the other hand, we stand ready and able to deliver a complete outsourced solution, across multiple continents, under the tightest of timeframes.

This flexibility and personalized service is why in a 2015 survey, APCER Life Sciences earned a perfect Net Promoter Score of 100. Every client surveyed said that they would highly recommend APCER as a service provider and viewed APCER favorably compared to large CROs and other specialty firms.

1

Global Presence

Adverse event reporting capabilities in 100+ countries and Medical Information coverage in 50+ countries and 30+ languages, scalable to 100+ languages.

2

Client Focus

We offer customized solutions to our clients through our flexible operational models, strong governance and collaborative approach.

3

Medicinal and Scientific Expertise

100+ physicians, 90% healthcare professionals respond to your calls, write your narratives and submit your reports to the regulatory agencies.

History

APCER Life Sciences is part of the APC Group, a global provider of active pharmaceutical ingredients (APIs) with an unblemished reputation for quality and support around the world.

APC was founded in 1987 in Hong Kong by APCER’s Chairman, Ravi Menon. The company grew rapidly by developing markets in India, China, and South East Asia for APIs and finished formulations produced by Western pharmaceutical manufacturers. Offices were added in Mumbai and Shanghai to satisfy the needs of both sellers and buyers.

As Asian manufacturers increased the quality of their products, APC Group was well positioned to provide APIs and finished formulations from India and China to the West and opened additional offices in Vietnam and Kazakhstan. APC also opened an office in Boston, MA, US, to provide regulatory, product selection, and consulting services to help its customers bridge the gap between China/India and the United States.

To respond to the increase in regulatory requirements around drug safety, APC expanded its services business with the formation of APCER Pharma Europe in 2007, headed by Dr. Vineet Kacker. The success of the business model and continued growth led to the establishment of APCER Pharma Solutions in the US. Today, these companies offer safety, medical, regulatory, and technology services around the world under the brand APCER Life Sciences.

Leadership Team

APCER Life Sciences is led by an impressive group of executives with hands-on expertise in safety, medical and regulatory affairs, technology, and project governance. All have experience in guiding global organizations to function together as a unified team.

Board of Directors

Ravi Menon
Chairman of the Board

Ravi has been a business leader and entrepreneur in the pharmaceutical industry for more than 40 years. The foundation of APC Group, which grew to encompass formulations, nutrients, consulting and services under his leadership, began in 1987 when Ravi moved to Hong Kong to pursue opportunities in the global trading of active pharmaceutical ingredients (APIs). Ravi has a vast network of relationships and an unblemished reputation throughout the industry.

Gopal Menon
Vice-Chairman

Gopal has more than 20 years’ experience in mergers and acquisitions, equity and debt financing, financial markets, and strategic advisory roles with international banks. He was Managing Director at ING and head of Asia Financial Institutions. He has since become an entrepreneur and an adviser on strategy and finance.

Tejus Menon
Executive Director

Tejus provides leadership and guidance to APCER in corporate strategy and marketing. He has experience in diverse markets, with a focus on healthcare in China, India, and Europe. Tejus began his career with the APC Group in Hong Kong, where he gained experience in the burgeoning Indian and Chinese markets. He has been a part of APCER Europe since its inception, working closely with the management and regulatory team in London.

Vineet Kacker, PhD
Managing Director and Global Technical Head

Vineet is a founder of APCER and has been a Qualified Person/Person Responsible for Pharmacovigilance for more than18 years. He earned a PhD in Pharmacology from All India Institute of Medical Sciences and transitioned his career path from academia to private industry over 19 years ago. Vineet managed the regulatory and pharmacovigilance functions with several pharma companies prior to joining APCER. He serves as one of our QPPVs in his current function and has successfully enabled sponsor compliance through numerous FDA and MHRA inspections.

John Kiley
Director

John has led the sales and service functions of the pharmaceutical products operations of APC Group since 2008. He has extensive experience in chemical and pharmaceutical operations and product development. Working in the industry for over 30 years, he has a broad and tested network for both sales and support. John earned a Bachelor of Science degree in Chemical Engineering from Tufts University.

Operational Leadership

Mark F. Faust, RPh
Director, Medical Information Services

Mark Faust is a Registered Pharmacist with extensive experience in directing the activities of global pharmaceutical contact centers. Mark has worked in the areas of global drug development, trade relations, and medical information for Bristol-Myers Squibb, Aventis Pharmaceuticals and Revlon Healthcare Group. He also has experience in labelling, post-marketing surveillance, promotional review, and clinical trials. With over 25 years in Medical Affairs, Mark has expertise supporting new-product launches, post-launch marketing campaigns, and direct-to-consumer/direct-to-physician programs. He has served as Medical Information Center lead for post-doctoral fellowships and diversity clerkships such as AAAG and Unidad Hispana.

Testimonials

  • Medical Director
    APCER’s speed, responsiveness and flexibility to meet our safety needs is something we have always valued. APCER has helped harmonize our global pharmacovigilance operations and made us compliant with ever changing regulations.
    Medical Director
    US-based specialty pharmaceutical company
  • QPPV and Pharmacovigilance Head
    The audit was carried out professionally and objectively. The scope of the audit was relevant and appropriate, and time efficient. The discussions during the audit were constructive and recommendations where helpful and appropriate. The team members involved in the audit had a positive experience and were made to feel at ease by the auditors.
    QPPV and Pharmacovigilance Head
  • Senior Director
    We are thankful to team APCER for bringing in strong practices & helping inspection readiness in our pharmacovigilance framework which led to successful FDA audits.
    Senior Director
    US-based pharmaceutical company
  • Head, Clinical Trial Transparency
    APCER’s invaluable support with Clinical trial disclosure deadlines helped us in timely submissions of periodic reports.
    Head, Clinical Trial Transparency
    Top 10 pharmaceutical company with operations in the EU and US
  • AVP, Pharmacovigilance
    We appreciate APCER for its efficiency in responding to matters that they get even at the eleventh hour. Working with APCER has made compliance a lot easier.
    AVP, Pharmacovigilance
    US-based pharmaceutical company
  • Senior Director
    We are thankful to team APCER for bringing in strong practices & helping inspection readiness in our pharmacovigilance framework which led to successful FDA audits.
    Senior Director
    US-based pharmaceutical company

How can we work together for better health?

    By clicking Submit, you agree to our Privacy Policy and to be contacted at the email and/or phone number you provided.